← Back to headlines
Moderna Begins First Human Trial of Bundibugyo Ebola Vaccine
Moderna has initiated the first human trial for its vaccine targeting the Bundibugyo strain of the Ebola virus.
Sources
Showing 0 of 1 sources
No articles available in your preferred languages.
1 article available in other languages below.
